BR112020003026A2 - ácidos nucleicos estabilizados codificando ácido ribonucleico mensageiro (mrna) - Google Patents
ácidos nucleicos estabilizados codificando ácido ribonucleico mensageiro (mrna) Download PDFInfo
- Publication number
- BR112020003026A2 BR112020003026A2 BR112020003026-0A BR112020003026A BR112020003026A2 BR 112020003026 A2 BR112020003026 A2 BR 112020003026A2 BR 112020003026 A BR112020003026 A BR 112020003026A BR 112020003026 A2 BR112020003026 A2 BR 112020003026A2
- Authority
- BR
- Brazil
- Prior art keywords
- adenine
- nucleotides
- poly
- dna
- consecutive
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/50—Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Crystallography & Structural Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762545883P | 2017-08-15 | 2017-08-15 | |
| US62/545,883 | 2017-08-15 | ||
| PCT/US2018/046772 WO2019036513A1 (en) | 2017-08-15 | 2018-08-14 | STABILIZED NUCLEIC ACIDS ENCODING MESSENGER RIBONUCLEIC ACID (MRNA) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112020003026A2 true BR112020003026A2 (pt) | 2020-08-25 |
Family
ID=63638316
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112020003026-0A BR112020003026A2 (pt) | 2017-08-15 | 2018-08-14 | ácidos nucleicos estabilizados codificando ácido ribonucleico mensageiro (mrna) |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US11673911B2 (https=) |
| EP (1) | EP3668980A1 (https=) |
| JP (2) | JP2020532961A (https=) |
| KR (2) | KR20250004924A (https=) |
| CN (2) | CN111212908B (https=) |
| AU (2) | AU2018318135B2 (https=) |
| BR (1) | BR112020003026A2 (https=) |
| CA (1) | CA3072960A1 (https=) |
| CO (1) | CO2020002989A2 (https=) |
| MX (1) | MX2020001821A (https=) |
| WO (1) | WO2019036513A1 (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES3015369T3 (en) * | 2014-10-09 | 2025-05-05 | Seattle Childrens Hospital Dba Seattle Childrens Res Inst | Long poly (a) plasmids and methods for introduction of long poly (a) sequences into the plasmid |
| AU2015330699B2 (en) | 2014-10-10 | 2021-12-02 | Editas Medicine, Inc. | Compositions and methods for promoting homology directed repair |
| EP3555297A1 (en) | 2016-12-19 | 2019-10-23 | Editas Medicine, Inc. | Assessing nuclease cleavage |
| JP7229923B2 (ja) | 2017-01-06 | 2023-02-28 | エディタス・メディシン、インコーポレイテッド | ヌクレアーゼ切断を評価する方法 |
| US11499151B2 (en) | 2017-04-28 | 2022-11-15 | Editas Medicine, Inc. | Methods and systems for analyzing guide RNA molecules |
| MX2019014640A (es) | 2017-06-09 | 2020-10-05 | Editas Medicine Inc | Nucleasas de repeticiones palíndromicas agrupadas y regularmente interespaciadas de proteina asociada 9 (cas9) genomanipuladas. |
| US11866726B2 (en) | 2017-07-14 | 2024-01-09 | Editas Medicine, Inc. | Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites |
| CA3072960A1 (en) * | 2017-08-15 | 2019-02-21 | Intellia Therapeutics, Inc. | Stabilized nucleic acids encoding messenger ribonucleic acid (mrna) |
| KR102832035B1 (ko) * | 2017-09-29 | 2025-07-09 | 인텔리아 테라퓨틱스, 인크. | 지질 나노파티클을 이용한 mRNA 전달의 체외 방법 |
| EP3823633A4 (en) | 2018-06-29 | 2023-05-03 | Editas Medicine, Inc. | SYNTHETIC LEAD MOLECULES, COMPOSITIONS AND METHODS RELATED THERETO |
| US12521451B2 (en) | 2019-11-08 | 2026-01-13 | Regeneron Pharmaceuticals, Inc. | CRISPR and AAV strategies for x-linked juvenile retinoschisis therapy |
| EP4389901A4 (en) * | 2021-08-17 | 2025-08-06 | Sk Bioscience Co Ltd | METHOD FOR STABLY MAINTAINING A POLY TAIL (A) |
| TW202325850A (zh) | 2021-11-29 | 2023-07-01 | 大陸商上海瑞宏迪醫藥有限公司 | Aadc、gdnf多核苷酸及其用於治療帕金森病 |
| AU2023220237A1 (en) | 2022-02-21 | 2024-08-15 | Shanghai Regenelead Therapies Co., Ltd | Vegf-binding molecule and pharmaceutical use thereof |
| CN117701602A (zh) * | 2022-08-26 | 2024-03-15 | 深圳瑞吉生物科技有限公司 | 在宿主细胞中稳定存在的多段化PolyA多核苷酸及其应用 |
| WO2024179544A1 (zh) * | 2023-03-01 | 2024-09-06 | 仁景(苏州)生物科技有限公司 | 编码rna的工程化dna分子 |
| TW202508610A (zh) | 2023-08-23 | 2025-03-01 | 大陸商上海瑞宏迪醫藥有限公司 | 醫藥組成物及其用途 |
| CN119799695A (zh) * | 2023-10-10 | 2025-04-11 | 深圳瑞吉生物科技有限公司 | 提高mRNA稳定性以及蛋白表达的多元polyA多核苷酸及其应用 |
| PL446809A1 (pl) * | 2023-11-22 | 2025-05-26 | Sieć Badawcza Łukasiewicz - PORT Polski Ośrodek Rozwoju Technologii | Cząsteczki RNA ze zmodyfikowanymi sekwencjami końca 3' i ich zastosowanie |
| WO2025128871A2 (en) | 2023-12-13 | 2025-06-19 | Renagade Therapeutics Management Inc. | Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents |
| GB202406051D0 (en) | 2024-04-30 | 2024-06-12 | Univ Oxford Innovation Ltd | Segmented poly(a) tails |
| WO2026006390A2 (en) | 2024-06-26 | 2026-01-02 | Intellia Therapeutics, Inc. | Modified guide rnas for genome editing |
| CN121628926A (zh) * | 2024-08-29 | 2026-03-10 | 仁景(苏州)生物科技有限公司 | 一种多价流感mRNA疫苗 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08131163A (ja) * | 1994-11-11 | 1996-05-28 | Sankyo Co Ltd | ドメイン変換ヘアピン型リボザイム |
| JP2002360299A (ja) * | 2001-04-20 | 2002-12-17 | Seiwa Technics:Kk | ｍＲＮＡの不安定性を利用したサイトカインの３’非翻訳領域を組み込んだトランスジェニックマウスのガン、炎症などの病変部位検出方法 |
| WO2012019630A1 (en) * | 2010-08-13 | 2012-02-16 | Curevac Gmbh | Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded protein |
| WO2013120500A1 (en) * | 2012-02-15 | 2013-08-22 | Curevac Gmbh | Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded tumour antigen |
| WO2016005004A1 (en) * | 2014-07-11 | 2016-01-14 | Biontech Rna Pharmaceuticals Gmbh | Stabilization of poly(a) sequence encoding dna sequences |
| ES3015369T3 (en) * | 2014-10-09 | 2025-05-05 | Seattle Childrens Hospital Dba Seattle Childrens Res Inst | Long poly (a) plasmids and methods for introduction of long poly (a) sequences into the plasmid |
| MA41349A (fr) * | 2015-01-14 | 2017-11-21 | Univ Temple | Éradication de l'herpès simplex de type i et d'autres virus de l'herpès associés guidée par arn |
| EP3085714B1 (en) * | 2015-04-21 | 2018-03-14 | Rohm And Haas Company | Co2 abating latex coating composition |
| WO2017059902A1 (en) * | 2015-10-07 | 2017-04-13 | Biontech Rna Pharmaceuticals Gmbh | 3' utr sequences for stabilization of rna |
| KR101786396B1 (ko) | 2016-10-27 | 2017-11-24 | 서울대학교산학협력단 | 전령 rna의 3′말단 서열 분석 방법 |
| CA3072960A1 (en) * | 2017-08-15 | 2019-02-21 | Intellia Therapeutics, Inc. | Stabilized nucleic acids encoding messenger ribonucleic acid (mrna) |
-
2018
- 2018-08-14 CA CA3072960A patent/CA3072960A1/en active Pending
- 2018-08-14 JP JP2020508506A patent/JP2020532961A/ja active Pending
- 2018-08-14 BR BR112020003026-0A patent/BR112020003026A2/pt not_active Application Discontinuation
- 2018-08-14 AU AU2018318135A patent/AU2018318135B2/en active Active
- 2018-08-14 CN CN201880066328.XA patent/CN111212908B/zh active Active
- 2018-08-14 WO PCT/US2018/046772 patent/WO2019036513A1/en not_active Ceased
- 2018-08-14 KR KR1020247040420A patent/KR20250004924A/ko active Pending
- 2018-08-14 CN CN202510029728.5A patent/CN119899831A/zh active Pending
- 2018-08-14 EP EP18772961.1A patent/EP3668980A1/en active Pending
- 2018-08-14 MX MX2020001821A patent/MX2020001821A/es unknown
- 2018-08-14 KR KR1020207007211A patent/KR102740888B1/ko active Active
-
2020
- 2020-02-14 US US16/791,076 patent/US11673911B2/en active Active
- 2020-03-13 CO CONC2020/0002989A patent/CO2020002989A2/es unknown
-
2023
- 2023-05-01 US US18/310,298 patent/US12391722B2/en active Active
- 2023-08-25 JP JP2023137160A patent/JP2023179428A/ja active Pending
-
2024
- 2024-12-04 AU AU2024278094A patent/AU2024278094A1/en not_active Abandoned
-
2025
- 2025-07-22 US US19/276,658 patent/US20250346625A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20250004924A (ko) | 2025-01-08 |
| AU2018318135A1 (en) | 2020-03-05 |
| AU2018318135B2 (en) | 2024-09-12 |
| US12391722B2 (en) | 2025-08-19 |
| KR20200036025A (ko) | 2020-04-06 |
| US20250346625A1 (en) | 2025-11-13 |
| US20200172564A1 (en) | 2020-06-04 |
| WO2019036513A1 (en) | 2019-02-21 |
| EP3668980A1 (en) | 2020-06-24 |
| CO2020002989A2 (es) | 2020-05-05 |
| AU2024278094A1 (en) | 2024-12-19 |
| KR102740888B1 (ko) | 2024-12-13 |
| CA3072960A1 (en) | 2019-02-21 |
| US20230271997A1 (en) | 2023-08-31 |
| CN111212908A (zh) | 2020-05-29 |
| JP2020532961A (ja) | 2020-11-19 |
| MX2020001821A (es) | 2020-09-18 |
| CN111212908B (zh) | 2025-01-24 |
| CN119899831A (zh) | 2025-04-29 |
| US11673911B2 (en) | 2023-06-13 |
| JP2023179428A (ja) | 2023-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12391722B2 (en) | Stabilized nucleic acids encoding messenger ribonucleic acid (mRNA) | |
| JP7618577B2 (ja) | 修飾環状ポリリボヌクレオチドを含む組成物及びその使用 | |
| KR102950624B1 (ko) | 원형 폴리리보뉴클레오티드를 포함하는 조성물 및 이의 용도 | |
| KR102728416B1 (ko) | A형 혈우병을 위한 유전자 편집용 조성물 및 방법 | |
| JP2023529316A (ja) | ゲノム編集のための組成物及び方法 | |
| EP3935162A1 (en) | Circular polyribonucleotides and pharmaceutical compositions thereof | |
| CN118256490A (zh) | 一种环状rna、组合物和治疗疾病的方法 | |
| CN110023494A (zh) | Rna指导的核酸修饰酶及其使用方法 | |
| WO2021155171A1 (en) | Delivery of compositions comprising circular polyribonucleotides | |
| WO2016138278A2 (en) | Compositions for inhibiting checkpoint gene expression and uses thereof | |
| JP2021504343A (ja) | 尿素サイクル異常症の治療のためのオルニチントランスカルバミラーゼをコードするポリヌクレオチド | |
| KR20250035055A (ko) | Pcsk9의 표적화를 위한 조성물 및 방법 | |
| TW201219569A (en) | Treatment of Sialidase 4 (NEU4) related diseases by inhibition of natural antisense transcript to NEU4 | |
| US20250223588A1 (en) | Oligonucleotides with 2'-deoxy-2'-f-2'-c-methyl nucleotides | |
| JP7560616B2 (ja) | 膜貫通型セリンプロテアーゼ６（ｔｍｐｒｓｓ６）発現を阻害するための組成物および方法 | |
| JP2024539089A (ja) | 修飾複製可能ｒｎａの機能および関連する組成物を増加させるための変異を決定する方法ならびにそれらの使用 | |
| WO2013056670A1 (zh) | 小干扰RNA及其应用和抑制plk1基因表达的方法 | |
| US20200362382A1 (en) | Methods of preparing modified rna | |
| CN117597446A (zh) | 非自然发生的5’-非转译区及3’-非转译区及其用途 | |
| HK40029231B (zh) | 编码信使核糖核酸(mRNA)的稳定核酸 | |
| HK40029231A (en) | Stabilized nucleic acids encoding messenger ribonucleic acid (mrna) | |
| HK40012328A (en) | Rna-guided nucleic acid modifying enzymes and methods of use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |